sorafenib has been researched along with iridium in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (iridium) | Trials (iridium) | Recent Studies (post-2010) (iridium) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 3,270 | 25 | 1,766 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuduwaili, W; Dong, L; Huang, AT; Li, Y; Liu, TT; Liu, ZY; Shen, XZ; Sun, JL; Wang, F; Wang, X; Weng, SQ; Xu, RC; Zhang, GC; Zhu, CF; Zhu, JM | 1 |
1 other study(ies) available for sorafenib and iridium
| Article | Year |
|---|---|
Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Iridium; Liver Neoplasms; Nanocomposites; Photochemotherapy; Photosensitizing Agents; Sorafenib | 2022 |